Radar › Companies › Biopharma Outsourcing · Montreal
Radar · Biopharma Outsourcing in Montreal

Best Biopharma Outsourcing Companies in Montreal, Canada

The 31 best Biopharma Outsourcing companies in Montreal, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CellCarta.

31companies tracked
$10.4Mdisclosed funding
0unicorns
4have raised
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × MONTREAL

Our analysis of 100 Biopharma Outsourcing companies

$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

100companies analysed
68%cloud-native stacks
2025funding peak (by rounds)
2008median founding year
50median Fliar Index™
175kcombined LinkedIn audience
69%of audience held by top 3
2companies hiring publicly (12 mo)

Ranked: Best Biopharma Outsourcing companies in Montreal

#CompanyDisclosed fundingEmployeesFounderFoundedTech stackWeb popularityRecent signals
1CellCarta
CRO focused on providing histopathology and genomics services
$8M727Dirk Hendriks
Co-Founder
2002WordPressPleskApple iCloud Mail+17Top 5M—
2Innovaderm
CRO providing full-service clinical trial solutions for dermatology drugs
—375—2000WordPressApple iCloud MailMicrosoft 365+33Top 5M—
3ITR Laboratories Canada
Provider of preclinical services specializing in toxicology testing services
—354—1989WordPressMySQLPHP+21Top 50M—
4JSS Medical Research
Full-service CRO providing clinical trial management services in 21+ countries
—200
200 → 406 (+103%)
—1997JoomlaApple iCloud MailMicrosoft 365+16Top 10M—
5Omega Laboratories
Manufacturer of specialized products for healthcare providers
—188Bruce Levins
President & CEO
1958———
6Algorithme Pharma
Full-service early stage CRO offering its services in the US and Canada
—137—1992———
7Laporte
Provider of infrastructure, automation, packaging and regulatory compliance services
—66—1999WordPressApple iCloud MailMySQL+21Top 5M—
8Imagia Canexia Health
CRO focused on oncology clinical services
—60—2022———

Top 4 Biopharma Outsourcing companies in Montreal

#1
Seed · Montreal, Quebec · founded 2020
$2.9Mraised
▾

Neurenati Therapeutics is a biotech company focused on developing therapies for rare diseases, with a current focus on Hirschsprung disease. The company recently concluded a $1.2 million seed financing round to advance the development of their NEU-001 therapy. CEO Maxime Ranger is a serial entrepreneur and venture capitalist in the life science space.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 746 LinkedIn followers
Funding rounds
  • Apr 2024Seed$1.7M
  • Feb 2024Seed$1.2M
Founders & team
Maxime RangerCEOMaxime RangerCEO
Investors
Invest Quebec
Tech stack
BootstrapCdnjsCloudflareComplianzContact Form 7Core-Js
#2
Acquired · Montreal, Quebec · founded 2002 · 727 employees
$7.5Mraised
▾

CRO focused on providing histopathology and genomics services. The company provides access to a broad offering of biomarker platforms and services. It provides a wide range of services which include Antigen presentation, Bioanalytical solutions, Bioinformatics, data mining biologics characterization, Immune profiling, and more.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 34k LinkedIn followers — 19.4% of this cohort's audience
Funding rounds
  • Sep 2014Grant (prize money)—
  • Sep 2009Grant (prize money)$891.3K
  • Feb 2009Series A$7.5M
  • Jun 2007Series A—
Founders & team
Dirk HendriksCo-FounderMartin LeblancCo-FounderDusty TenneyChief Executive Officer
Investors
The Michael J. Fox Foundation, Waters Corporation, Great Point Partners, HHS, Arsenal Capital Partners, 3 Boomerang Capital
Tech stack
Apple Icloud MailAzureJqueryMicrosoft 365MysqlNginx
#3
Seed · Montreal, Quebec · founded 2022
—raised
▾

RNA Technologies is a biotechnology research company focused on RNA services and therapeutics. They are committed to advancing medical science and revolutionizing healthcare through cutting-edge technology.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
  • Feb 2024Seed—
Founders & team
Nicolas KhanhCo-FounderOusamah SolimanCo-FounderWilliam PeranteauCo-Founder
Tech stack
CloudflareCloudflare Bot ManagementCore-JsGodaddyGoogle AnalyticsGoogle Font Api
#4
Acquired · Montreal, Montreal · founded 1997 · 200 employees
—raised
▾

JSS Medical Research is a CRO providing medical research services to pharmaceutical, biotechnology, nutraceutical and medical device companies with their pre- and post-approval clinical development, and reimbursement goals and strategies. It provides comprehensive clinical trial management services from study design to publication of results, in Phase I-IV trials across a broad range of therapeutic areas. It claims that it is currently conducting research studies in over 21 countries.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 29k LinkedIn followers — 16.8% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Senior Medical Writer (Clinical Manuscripts)
Funding rounds
  • Oct 2014Unattributed—
Investors
Capital croissance PME
Tech stack
Apache Http ServerApple Icloud MailBootstrapDocusignGodaddyGoogle Analytics

Funding & investor landscape

$10.4Mtotal disclosed funding
2companies funded
4disclosed rounds
0rounds last 90 days
Most active investors
3 Boomerang Capital1 rounds
Arsenal Capital Partners1 rounds
Capital croissance PME1 rounds
Great Point Partners1 rounds
HHS1 rounds
Invest Quebec1 rounds
Oakwood Medical1 rounds
The Michael J. Fox Foundation1 rounds
Waters Corporation1 rounds

Notable founders

Maxime Ranger
CEO · Neurenati
Dirk Hendriks
Co-Founder · CellCarta
Martin Leblanc
Co-Founder · CellCarta
Nicolas Khanh
Co-Founder · RNA Technologies and Therapeutics
Ousamah Soliman
Co-Founder · RNA Technologies and Therapeutics
Prism market signals · Canada · country-scoped Prism corpus, 143,639 docs

Market landscape — 10 sub-themes by coverage

Share of Biopharma Outsourcing coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH FROM Montreal · institutions

What Montreal researches in biotechnology

20 papersstance +0.5371% breakthrough0% concern
breakthrough · advancement · concern
local research themes
Developmental Biology and Gene RegulationImmunodeficiency and Autoimmune DisordersGlycogen Storage Diseases and MyoclonusRNA Research and SplicingT-cell and B-cell ImmunologyGenomics and Chromatin Dynamics
top institutions
  • Montreal Clinical Research Institute9
  • Montreal Neurological Institute and Hospital8
  • Montreal Children\'s Hospital2
  • Montreal Biodome1

Common questions

How many Biopharma Outsourcing companies are there in Montreal, Canada?
Radar tracks 31 indexable Biopharma Outsourcing companies headquartered in Montreal, Canada that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in Montreal, Canada?
The Biopharma Outsourcing companies in Montreal, Canada on this list have raised a combined $10.4M in disclosed equity funding across 2 funded companies.
Which is the highest-funded Biopharma Outsourcing company in Montreal, Canada?
CellCarta is the highest-funded Biopharma Outsourcing company in Montreal, Canada, with $7.5M in disclosed equity funding.
How many Biopharma Outsourcing companies in Montreal, Canada are funded?
2 of the 31 Biopharma Outsourcing companies in Montreal, Canada on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in Montreal, Canada?
None of the Biopharma Outsourcing companies in Montreal, Canada on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Montreal, Canada Biopharma Outsourcing companies?
The most active investors in Montreal, Canada Biopharma Outsourcing companies on this list include 3 Boomerang Capital, Arsenal Capital Partners, Capital croissance PME, Great Point Partners, HHS.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon